169 related articles for article (PubMed ID: 12843138)
1. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
J Clin Endocrinol Metab; 2003 Jul; 88(7):3021-6. PubMed ID: 12843138
[TBL] [Abstract][Full Text] [Related]
2. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
Vitale M; Di Matola T; Rossi G; Laezza C; Fenzi G; Bifulco M
Endocrinology; 1999 Feb; 140(2):698-704. PubMed ID: 9927296
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
4. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
Cancer; 2002 Nov; 95(9):1827-33. PubMed ID: 12404274
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract][Full Text] [Related]
11. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
[TBL] [Abstract][Full Text] [Related]
12. Proteomics and bioinformatics analysis of lovastatin-induced differentiation in ARO cells.
Shui HA; Hsia CW; Chen HM; Chang TC; Wang CY
J Proteomics; 2012 Feb; 75(4):1170-80. PubMed ID: 22086082
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
Rabkin SW; Tsang MY
Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARĪ³-dependent pathway.
Walther U; Emmrich K; Ramer R; Mittag N; Hinz B
Oncotarget; 2016 Mar; 7(9):10345-62. PubMed ID: 26863638
[TBL] [Abstract][Full Text] [Related]
15. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
16. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
17. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.
Park C; Lee I; Kang WK
Carcinogenesis; 2001 Oct; 22(10):1727-31. PubMed ID: 11577016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]